Dubai, January 27, 2012
An estimated 72,000 healthcare professionals gathered at the Dubai World Trade Centre Jan. 23-26 for the 2012 Arab Health Congress and Exhibition. The meeting also provided the framework for the 2nd Multi-Disciplinary Approach to Cancer Therapy Conference.
During the exhibition, Elekta demonstrated advanced solutions
ranging from conventional radiation therapy with Elekta
Compact™* to stereotactic neurosurgery with Leksell Gamma
Knife® Perfexion™, products that provide clinicians with the
tools to save and improve the lives of individuals with
cancer. In addition, for the first time at Arab Health,
Elekta presented advanced brachytherapy solutions.
The theme of the Elekta exhibit was "Experience the Elekta
Difference," which emphasizes the company's commitment to
increasing the user's clinical confidence by simplifying the
variables in treatment planning, patient setup, verification
and delivery.
"Elekta was honored to attend Arab Health once again as a
Gold Sponsor for the 2nd Multi-Disciplinary Approach to
Cancer Therapy Conference," says Nabil Elias Romanos,
Elekta's Vice President, Eastern Europe and Middle East. "We
enjoyed heavy booth traffic and were gratified by the
interest in our entire product portfolio, including our
brachytherapy solutions. Many of the discussions with
hospital administrators and clinicians revolved around key
partnerships in the regions, supported by education, training
and clinical collaboration."
In 2012, Elekta will increase its presence in the region,
after having already expanded its Dubai office to better
serve customers and partners.
According to World Health Organization (WHO), cancer is the
fourth-ranked cause of death in the wider Middle East Region.
The top five cancers in the region, when males and females
are combined, are breast, bladder, lung, oral and colon
cancer. In addition, the largest increase in cancer incidence
in the WHO regions in the next 15 years is likely to be in
the wider Middle East Region.
"The unmet need of cancer care will continue to drive demand
in Eastern Europe and the Middle East," Romanos adds. "In
these regions, Elekta is committed to providing meaningful
support over the wide spectrum of cancer management, combined
with personalized training, as well as scalable offerings and
services."
.
*Elekta Compact™ is not available for sale or distribution in
all regions. Please contact your local Elekta representative
or authorized distributor for further details.
###
For further information, please contact:
Stina Thorman, Vice President Corporate Communications,
Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time
Michelle Lee Joiner, Director, Global Public Relations and
Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: .
distribué par | Ce noodl a été diffusé par Elekta AB et initialement mise en ligne sur le site http://www.elekta.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-27 16:15:12 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |